VIDEREGEN LTD has a total of 22 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), Australia and China. Its main competitors in its focus markets medical technology, biotechnology and pharmaceuticals are SYNTHASOME INC, YE CHUAN and KOREA BONE BANK CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 3 | |
#3 | China | 3 | |
#4 | Republic of Korea | 3 | |
#5 | Canada | 2 | |
#6 | United Kingdom | 2 | |
#7 | Hong Kong | 2 | |
#8 | United States | 2 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Biotechnology | |
#3 | Pharmaceuticals | |
#4 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Object sterilising | |
#2 | Implantable devices | |
#3 | Polysaccharides | |
#4 | Therapeutic chemical compounds | |
#5 | Microorganisms | |
#6 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Sibbons Paul David | 18 |
#2 | Ansari Tahera Iqbal | 18 |
#3 | Paul David Sibbons | 2 |
#4 | Tahera Iqbal Ansari | 2 |
#5 | Ansari Tahera | 1 |
#6 | Tahera Ansari | 1 |
Publication | Filing date | Title |
---|---|---|
GB201518657D0 | Decellularising tissue | |
KR20160021256A | Implant and method of producing an implant by decellularising an tissue by perfusion under negative pressure | |
EP2874674A1 | Implant and method for producing an implant |